Suad Hannawi1, Haifa Hannawi1,2, Kashif Bin Naeem1, Noha Mousaad Elemam3,4, Mahmood Y Hachim5, Ibrahim Y Hachim3,4, Abdulla Salah Darwish6, Issa Al Salmi7,8. 1. Department of Medicine, Ministry of Health and Prevention, Dubai, United Arab Emirates. 2. Department of Reserach, Ministry of Health and Prevention, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates. 3. Sharjah Institute for Medical Research, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. 4. Clinical Sciences Department, College of Medicine, University of Sharjah, Sharjah, United Arab Emirates. 5. College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, United Arab Emirates. 6. Gullf Medical School, Ajman, Gulf Medical University, Ajman, United Arab Emirates. 7. Department of Medicine, Oman Medical Specialty Board, The Royal Hospital, Muscat, Oman. 8. The Research Section, Oman Medical Speciality Board, The Royal Hospital, Muscat, Oman.
Abstract
Introduction: COVID-19 is raising with a second wave threatening many countries. Therefore, it is important to understand COVID-19 characteristics across different countries. Methods: This is a cross-sectional descriptive study of 525 hospitalized symptomatic COVID-19 patients, from the central federal hospital in Dubai-UAE during period of March to August 2020. Results: UAE's COVID-19 patients were relatively young; mean (SD) of the age 49(15) years, 130 (25%) were older than 60 and 4 (<1%) were younger than 18 years old. Majority were male(47; 78%). The mean (SD) BMI was 29 (6) kg/m2. While the source of contracting COVID-19 was not known in 369 (70%) of patients, 29 (6%) reported travel to overseas-country and 127 (24%) reported contact with another COVID-19 case/s. At least one comorbidity was present in 284 (54%) of patients and 241 (46%) had none. The most common comorbidities were diabetes (177; 34%) and hypertension (166; 32%). The mean (SD) of symptoms duration was 6 (3) days. The most common symptoms at hospitalization were fever (340; 65%), cough (296; 56%), and shortness of breath (SOB) (243; 46%). Most of the laboratory values were within normal range, but (184; 35%) of patients had lymphopenia, 43 (8%) had neutrophilia, and 116 (22%) had prolong international normalized ratio (INR), and 317 (60%) had high D-dimer. Chest x ray findings of consolidation was present in 334 (64%) of patients and CT scan ground glass appearance was present in 354 (68%). Acute cardiac injury occurred in 124 (24%), acute kidney injury in 111 (21%), liver injury in 101 (19%), ARDS in 155 (30%), acidosis in 118 (22%), and septic shock in 93 (18%). Consequently, 150 (29%) required ICU admission with 103 (20%) needed mechanical ventilation. Conclusions: The study demonstrated the special profile of COVID-19 in UAE. Patients were young with diabetes and/or hypertension and associated with severe infection as shown by various clinical and laboratory data necessitating ICU admission.
Introduction: COVID-19 is raising with a second wave threatening many countries. Therefore, it is important to understand COVID-19 characteristics across different countries. Methods: This is a cross-sectional descriptive study of 525 hospitalized symptomatic COVID-19patients, from the central federal hospital in Dubai-UAE during period of March to August 2020. Results: UAE's COVID-19patients were relatively young; mean (SD) of the age 49(15) years, 130 (25%) were older than 60 and 4 (<1%) were younger than 18 years old. Majority were male(47; 78%). The mean (SD) BMI was 29 (6) kg/m2. While the source of contracting COVID-19 was not known in 369 (70%) of patients, 29 (6%) reported travel to overseas-country and 127 (24%) reported contact with another COVID-19 case/s. At least one comorbidity was present in 284 (54%) of patients and 241 (46%) had none. The most common comorbidities were diabetes (177; 34%) and hypertension (166; 32%). The mean (SD) of symptoms duration was 6 (3) days. The most common symptoms at hospitalization were fever (340; 65%), cough (296; 56%), and shortness of breath (SOB) (243; 46%). Most of the laboratory values were within normal range, but (184; 35%) of patients had lymphopenia, 43 (8%) had neutrophilia, and 116 (22%) had prolong international normalized ratio (INR), and 317 (60%) had high D-dimer. Chest x ray findings of consolidation was present in 334 (64%) of patients and CT scan ground glass appearance was present in 354 (68%). Acute cardiac injury occurred in 124 (24%), acute kidney injury in 111 (21%), liver injury in 101 (19%), ARDS in 155 (30%), acidosis in 118 (22%), and septic shock in 93 (18%). Consequently, 150 (29%) required ICU admission with 103 (20%) needed mechanical ventilation. Conclusions: The study demonstrated the special profile of COVID-19 in UAE. Patients were young with diabetes and/or hypertension and associated with severe infection as shown by various clinical and laboratory data necessitating ICU admission.
Authors: Ayman Tailakh; Lorraine S Evangelista; Janet C Mentes; Nancy A Pike; Linda R Phillips; Donald E Morisky Journal: Nurs Health Sci Date: 2013-09-30 Impact factor: 1.857
Authors: Sabrina Bimonte; Anna Crispo; Alfonso Amore; Egidio Celentano; Arturo Cuomo; Marco Cascella Journal: In Vivo Date: 2020-06 Impact factor: 2.155
Authors: Kashif B Naeem; Mahmood Y Hachim; Ibrahim Y Hachim; Ayman Chkhis; Rajesh Quadros; Haifa Hannawi; Issa Al Salmi; Fahdah Alokaily; Suad Hannawi Journal: Saudi Med J Date: 2020-11 Impact factor: 1.484
Authors: Saadia Omer; Mehrunnisa Fatima Gondal; Muhammad Usman; Muhammad Bilal Sarwar; Muhammad Roman; Alam Khan; Nadeem Afzal; Tanveer Ahmed Qaiser; Muhammad Yasir; Faheem Shahzad; Romeeza Tahir; Saima Ayub; Javed Akram; Raja Muhammad Faizan; Muhammad Asif Naveed; Shah Jahan Journal: Front Cell Infect Microbiol Date: 2022-05-26 Impact factor: 6.073
Authors: Ibrahim Y Hachim; Mahmood Y Hachim; Haifa Hannawi; Kashif Bin Naeem; Abdulla Salah; Suad Hannawi Journal: PLoS One Date: 2021-12-02 Impact factor: 3.240